In adults with type 2 diabetes and advanced kidney disease, a weekly injection of semaglutide at 1.0 mg lowers the combined risk of kidney failure, severe loss of kidney function, or death from heart...
Mechanism
Synthesis from 1 study
Semaglutide helps the kidneys and heart by lowering pressure inside the kidney filters and reducing swelling, which stops them from getting damaged. It also helps the body use sugar better and lowers blood pressure, which keeps the heart from working too hard.
Most probable mechanism
Semaglutide helps the kidneys work more gently by lowering the pressure inside their filtering units and reducing swelling, which keeps them from getting damaged over time. It also helps the heart by improving how it uses sugar and lowering blood pressure, which together lowers the chance of serious problems like heart attacks or kidney failure.
Semaglutide activates GLP-1 receptors in the kidney, leading to afferent arteriolar vasoconstriction and reduced glomerular intracapillary pressure
Reduced glomerular pressure decreases mechanical stress on podocytes and tubular cells, limiting structural damage and protein leakage
GLP-1 receptor activation suppresses pro-inflammatory cytokine production and macrophage infiltration in renal tissue
Improved glycemic control and reduced body weight decrease systemic insulin resistance and vascular endothelial dysfunction
Lowered blood pressure and reduced arterial stiffness decrease cardiac afterload and myocardial oxygen demand
Evidence from Studies
Supporting (1)
Community contributions welcome
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.